Monday, October 29, 2018

Genoptix Acquired By NeoGenomics

San Diego-based Genoptix, a clinical oncology laboratory that specializes in hematology and solid tumor testing was acquired by Florida-based NeoGenomics, the firms said last week. The deal was worth $125M in cash plus 1 million shares of NeoGenomics common stock, or approximately $139M. NeoGenomics is a

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.